Prevalence of human papillomavirus type 16 and its variants in abnormal squamous cervical cells in Northeast Thailand

International Journal of Infectious Diseases

Volumn 13, Issue 2, 2009, Pages 212-219

  Chopjitt, Peechanika ^a   Ekalaksananan, Tipaya ^a   Pientong, Chamsai ^a   Kongyingyoes, Bunkerd ^a   Kleebkaow, Pilaiwan ^a   Charoensri, Nicha ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

Author keywords

HPV16 prevalence; HPV16 variants; Northeast Thailand

Indexed keywords

ARTICLE; CANCER SCREENING; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREVALENCE; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS CARCINOGENESIS; VIRUS IDENTIFICATION;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA, VIRAL; FEMALE; GENETIC VARIATION; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREVALENCE; REPRESSOR PROTEINS; THAILAND; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 60849097829     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijid.2008.06.017     Document Type: Article

References (32)

1. Baseman J.G., and Koutsky L.A. The epidemiology of human papillomavirus infections. J Clin Virol 32 Suppl 1 (2005) S16-24
2. Thomas D.B., Qin Q., Kuypers J., Kiviat N., Ashley R.L., Koetsawang A., et al. Human papillomaviruses and cervical cancer in Bangkok. II. Risk factors for in situ and invasive squamous cell cervical carcinomas. Am J Epidemiol 153 (2001) 732-739
3. Chichareon S., Herrero R., Munoz N., Bosch F.X., Jacobs M.V., Deacon J., et al. Risk factors for cervical cancer in Thailand: a case-control study. J Natl Cancer Inst 90 (1998) 50-57
4. Sriamporn S., Snijders P.J., Pientong C., Pisani P., Ekalaksananan T., Meijer C.J., et al. Human papillomavirus and cervical cancer from a prospective study in Khon Kaen, Northeast Thailand. Int J Gynecol Cancer 16 (2006) 266-269
5. Ekalaksananan T., Pientong C., Sriamporn S., Kongyingyoes B., Pengsa P., Kleebkaow P., et al. Usefulness of combining testing for p16 protein and human papillomavirus (HPV) in cervical carcinoma screening. Gynecol Oncol 103 (2006) 62-66
6. Sukvirach S., Smith J.S., Tunsakul S., Munoz N., Kesararat V., Opasatian O., et al. Population-based human papillomavirus prevalence in Lampang and Songkla, Thailand. J Infect Dis 187 (2003) 1246-1256
7. Bhattarakosol P., Poonnaniti A., and Niruthisard S. Detection and typing of human papillomavirus in cervical cancer in the Thai. J Med Assoc Thai 79 Suppl 1 (1996) S56-64
8. Sukvirach S., Pitakpraisan P., Kosiyatrakul T., and Hankittipongpaisarn P. Detection of human papillomavirus DNA in normal and cervical carcinoma tissue of Thai females. Thai Cancer J 20 (1994) 85-91
9. Ekalaksananan T., Sriamporn S., Vatanasapt V., Pientong C., Kongyingyoes B., Pengsaa P., et al. Human papillomavirus infection in rural women in Khon Kaen, Thailand. Thai Cancer J 22 (1996) 85-92
10. Chaiwongkot A., Pientong C., Ekalaksananan T., Kongyingyoes B., Thinkhamrop J., Yuenyao P., et al. Evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells. Asian Pac J Cancer Prev 8 (2007) 279-282
11. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X., et al. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J Virol 71 (1997) 2463-2472
12. Zehbe I., Wilander E., Delius H., and Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res 58 (1998) 829-833
13. Bible J.M., Mant C., Best J.M., Kell B., Starkey W.G., Shanti Raju K., et al. Cervical lesions are associated with human papillomavirus type 16 intratypic variants that have high transcriptional activity and increased usage of common mammalian codons. J Gen Virol 81 (2000) 1517-1527
14. Etherington I.J., Ellis J.R., Luesley D.M., Moffitt D.D., and Young L.S. Histologic and immunologic associations of an HPV16 variant in LoSIL smears. Gynecol Oncol 72 (1999) 56-59
15. Matsumoto K., Yoshikawa H., Nakagawa S., Tang X., Yasugi T., Kawana K., et al. Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population. Cancer Lett 156 (2000) 159-165
16. Berumen J., Ordonez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 93 (2001) 1325-1330
17. Chan P.K., Lam C.W., Cheung T.H., Li W.W., Lo K.W., Chan M.Y., et al. Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China. J Infect Dis 186 (2002) 696-700
18. van den Brule A.J., Pol R., Fransen-Daalmeijer N., Schouls L.M., Meijer C.J., and Snijders P.J. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40 (2002) 779-787
19. de Boer M.A., Peters L.A., Aziz M.F., Siregar B., Cornain S., Vrede M.A., et al. Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands. Gynecol Oncol 94 (2004) 488-494
20. Clifford G.M., Smith J.S., Plummer M., Munoz N., and Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 88 (2003) 63-73
21. Remmerbach T.W., Brinckmann U.G., Hemprich A., Chekol M., Kuhndel K., and Liebert U.G. PCR detection of human papillomavirus of the mucosa: comparison between MY09/11 and GP5+/6+ primer sets. J Clin Virol 30 (2004) 302-308
22. Clifford G.M., Gallus S., Herrero R., Munoz N., Snijders P.J., Vaccarella S., et al. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet 366 (2005) 991-998
23. Kang S., Jeon Y.T., Kim J.W., Park N.H., Song Y.S., Kang S.B., et al. Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women. Int J Gynecol Cancer 15 (2005) 107-112
24. Lizano M., De la Cruz-Hernandez E., Carrillo-Garcia A., Garcia-Carranca A., Ponce de Leon-Rosales S., Duenas-Gonzalez A., et al. Distribution of HPV16 and 18 intratypic variants in normal cytology, intraepithelial lesions, and cervical cancer in a Mexican population. Gynecol Oncol 102 (2006) 230-235
25. Stevens M.P., Tabrizi S.N., Quinn M.A., and Garland S.M. Human papillomavirus genotype prevalence in cervical biopsies from women diagnosed with cervical intraepithelial neoplasia or cervical cancer in Melbourne, Australia. Int J Gynecol Cancer 16 (2006) 1017-1024
26. Vaeteewoottacharn K., Jearanaikoon P., and Ponglikitmongkol M. Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas. Anticancer Res 23 (2003) 1927-1931
27. Choi B.S., Kim S.S., Yun H., Jang D.H., and Lee J.S. Distinctive distribution of HPV16 E6 D25E and E7 N29S intratypic Asian variants in Korean commercial sex workers. J Med Virol 79 (2007) 426-430
28. Xi L.F., Koutsky L.A., Galloway D.A., Kuypers J., Hughes J.P., Wheeler C.M., et al. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J Natl Cancer Inst 89 (1997) 796-802
29. Hildesheim A., and Wang S.S. Host and viral genetics and risk of cervical cancer: a review. Virus Res 89 (2002) 229-240
30. Grodzki M., Besson G., Clavel C., Arslan A., Franceschi S., Birembaut P., et al. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol Biomarkers Prev 15 (2006) 820-822
31. Saiki R.K., Gelfand D.H., Stoffel S., Scharf S.J., Higuchi R., Horn G.T., et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239 (1988) 487-491
32. Jacobs M.V., de Roda Husman A.M., van den Brule A.J., Snijders P.J., Meijer C.J., and Walboomers J.M. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol 33 (1995) 901-905